2 directorsName after signing inVisible after signing in and 1 other
Documentsfilings and deeds
07-07-202624 days before the deadline
2025abbreviated format
Gross margin from €71,160 to €178,051Result from €43,462 to €137,007Equity from €1.1m to €1.2mDebts from €591,834 to €2.4mInvestments €2.0mCash from €24,350 to €4,502
Five of the last ten came late. The 2021 accounts came in latest, 60 days after the end of the period.
Checked score
Outside the general model
Checked score
The higher the Checked score (0 to 100), the smaller the chance that the company goes bankrupt within twelve months. That chance sets the band, from Critical to Excellent, and within the band how the company does against its sector peers counts too. With a low score, agree a shorter payment term, an advance or security.
Model not applicable to financial institutions
The Checked score measures liquidity, leverage and margins against the norms for trading and manufacturing companies. A bank, insurer or financial holding has a very different balance sheet. Those ratios and the score mean nothing here. So there is no financial strength either.
Bankruptcy probability within 12 months
Bankruptcy probability
It is the chance that the company goes bankrupt within twelve months, estimated from the registers, the annual accounts and the Belgian Official Gazette. At 0.2%, about 2 in 1,000 comparable companies go bankrupt. The higher it is, the shorter the payment term to agree.
The company is a financial institution: a bank, insurer or financial holding. Its balance sheet works differently from that of a trading or manufacturing company. A bankruptcy probability from the general model would mislead here.
Credit check for an amount and term of your choice
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0833903555
Name hiddenVisible after signing in appointed as director
General meeting of 01-07-2024 · Gazette deed
Hidden nameVisible after signing in reappointed as director
Legal-form conversion: from private limited company (pre-2019) to private limited company · General meeting of 18-08-2023 · Gazette deed
Registered office moved within Vremde
The registered office moved from Weverstraat 41, 2531 Vremde to Vremdesesteenweg 259, 2531 Vremde · Gazette deed
Sector peers are the companies with the same activity (NACE code) and, where stated, the same size, that the company is compared with. A percentile says how many of them do worse.
These companies have the same main activity as LIBRA PHARMA: activities of holding companies (NACE 64210). They are comparable in size and age: total assets between €2.7m and €4.4m, founded between 2010 and 2012.
The company number of LIBRA PHARMA is 0833.903.555. The VAT number is the same number with BE in front: BE 0833.903.555.
Where is LIBRA PHARMA based?
The registered office is at Vremdesesteenweg 259, 2531 Boechout.Company details
What does LIBRA PHARMA do?
According to the KBO register, the main activity is activities of holding companies (NACE 64210).
What is the legal form of LIBRA PHARMA?
LIBRA PHARMA is a private limited company (BV).
When was LIBRA PHARMA founded?
LIBRA PHARMA was founded on 16-02-2011.
Is LIBRA PHARMA still active?
Yes, LIBRA PHARMA is an active enterprise in the KBO register.
How many employees does LIBRA PHARMA have?
LIBRA PHARMA had an average of 0.8 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does LIBRA PHARMA fall under?
In its 2025 annual accounts, LIBRA PHARMA states joint committee 313 (Pharmacies and pricing offices).
What is the turnover of LIBRA PHARMA?
The turnover in financial year 2025 is ≈ €280,000. This figure is estimated from the gross margin of €178,051 and 33 comparable companies (NACE 64210). It probably lies between €240,000 and €350,000.
Is LIBRA PHARMA profitable?
In financial year 2025, LIBRA PHARMA made a profit of €137,007.
Where can I find the annual accounts of LIBRA PHARMA?
LIBRA PHARMA filed 14 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of LIBRA PHARMA due?
LIBRA PHARMA must file the annual accounts for financial year 2026 by 31-07-2027.Timeline